These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2459233)

  • 1. Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes.
    Kammer GM; Walter EI; Medof ME
    J Immunol; 1988 Nov; 141(9):2924-8. PubMed ID: 2459233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells.
    Tausk F; Fey M; Gigli I
    J Immunol; 1989 Nov; 143(10):3295-302. PubMed ID: 2478622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A; Goldmacher V; Reiser H; Rock KL
    J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay-accelerating factor functions as a signal transducing molecule for human T cells.
    Davis LS; Patel SS; Atkinson JP; Lipsky PE
    J Immunol; 1988 Oct; 141(7):2246-52. PubMed ID: 2459203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of decay-accelerating factor and HLA-DR within the CD8-brightly positive population.
    Tomita A; Okada N; Okada H
    Eur J Immunol; 1991 Aug; 21(8):1843-8. PubMed ID: 1714392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF).
    Nicholson-Weller A; Russian DA; Austen KF
    J Immunol; 1986 Aug; 137(4):1275-9. PubMed ID: 3090145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.
    Walter EI; Roberts WL; Rosenberry TL; Ratnoff WD; Medof ME
    J Immunol; 1990 Feb; 144(3):1030-6. PubMed ID: 1688588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody.
    Cole JA; McCarthy SA; Rees MA; Sharrow SO; Singer A
    J Immunol; 1989 Jul; 143(2):397-402. PubMed ID: 2786906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of decay-accelerating factor (DAF) from Raji cells.
    Fujita T; Shinkai Y; Inoue T; Tamura N
    Immunology; 1988 Jul; 64(3):369-74. PubMed ID: 2457546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa.
    Cervoni F; Oglesby TJ; Fénichel P; Dohr G; Rossi B; Atkinson JP; Hsi BL
    J Immunol; 1993 Jul; 151(2):939-48. PubMed ID: 7687624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of autologous antibodies and decay-accelerating factor, an inhibitor of complement, on human renal tumor cells.
    Terachi T; Stanescu G; Pontes JE; Medof ME; Caulfield MJ
    Cancer Res; 1991 May; 51(10):2521-3. PubMed ID: 1708695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional forms of human decay-accelerating factor (DAF).
    Seya T; Farries T; Nickells M; Atkinson JP
    J Immunol; 1987 Aug; 139(4):1260-7. PubMed ID: 2440950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
    Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface.
    Tsuji S; Kaji K; Nagasawa S
    J Immunol; 1994 Feb; 152(3):1404-10. PubMed ID: 7507966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.